BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Di Gregorio J, Robuffo I, Spalletta S, Giambuzzi G, De Iuliis V, Toniato E, Martinotti S, Conti P, Flati V. The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders. Front Cell Dev Biol 2020;8:607483. [PMID: 33409282 DOI: 10.3389/fcell.2020.607483] [Cited by in Crossref: 8] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Munakarmi S, Gurau Y, Shrestha J, Risal P, Park HS, Shin HB, Jeong YJ. Hepatoprotective Effects of a Natural Flavanol 3,3′-Diindolylmethane against CCl4-Induced Chronic Liver Injury in Mice and TGFβ1-Induced EMT in Mouse Hepatocytes via Activation of Nrf2 Cascade. IJMS 2022;23:11407. [DOI: 10.3390/ijms231911407] [Reference Citation Analysis]
2 Xu X, Poulsen KL, Wu L, Liu S, Miyata T, Song Q, Wei Q, Zhao C, Lin C, Yang J. Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH). Signal Transduct Target Ther 2022;7:287. [PMID: 35963848 DOI: 10.1038/s41392-022-01119-3] [Reference Citation Analysis]
3 Yip KM, Lee KM, Ng TB, Xu S, Yung KKL, Qu S, Cheung AKL, Sze SCW. An anti-inflammatory and anti-fibrotic proprietary Chinese medicine nasal spray designated as Allergic Rhinitis Nose Drops (ARND) with potential to prevent SARS-CoV-2 coronavirus infection by targeting RBD (Delta)- angiotensin converting enzyme 2 (ACE2) binding. Chin Med 2022;17:88. [PMID: 35897044 DOI: 10.1186/s13020-022-00635-2] [Reference Citation Analysis]
4 Confalonieri P, Volpe MC, Jacob J, Maiocchi S, Salton F, Ruaro B, Confalonieri M, Braga L. Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF). Cells 2022;11:2095. [DOI: 10.3390/cells11132095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sun Y, Lyu M, Lu Q, Cheung K, Leung V. Current Perspectives on Nucleus Pulposus Fibrosis in Disc Degeneration and Repair. Int J Mol Sci 2022;23:6612. [PMID: 35743056 DOI: 10.3390/ijms23126612] [Reference Citation Analysis]
6 Sehgal M, Jakhete S, Manekar A, Sasikumar S. Specific epigenetic regulators serve as potential therapeutic targets in idiopathic pulmonary fibrosis. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e09773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ye Z, Xia Y, Zhou X, Li B, Yu W, Ruan Y, Li H, Ning J, Chen L, Rao T, Cheng F. CXCR4 inhibition attenuates calcium oxalate crystal deposition-induced renal fibrosis. International Immunopharmacology 2022;107:108677. [DOI: 10.1016/j.intimp.2022.108677] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Alsayed HA, Mohammad HMF, Khalil CM, El-Kherbetawy MK, Elaidy SM. Autophagy modulation by irbesartan mitigates the pulmonary fibrotic alterations in bleomycin challenged rats: Comparative study with rapamycin. Life Sci 2022;303:120662. [PMID: 35636582 DOI: 10.1016/j.lfs.2022.120662] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Effendi WI, Nagano T. Connective Tissue Growth Factor in Idiopathic Pulmonary Fibrosis: Breaking the Bridge. IJMS 2022;23:6064. [DOI: 10.3390/ijms23116064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ruscitti P, Liakouli V, Panzera N, Angelucci A, Berardicurti O, Di Nino E, Navarini L, Vomero M, Ursini F, Mauro D, Dolo V, Ciccia F, Giacomelli R, Cipriani P. Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6. Pharmaceuticals 2022;15:622. [DOI: 10.3390/ph15050622] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sakowska J, Arcimowicz Ł, Jankowiak M, Papak I, Markiewicz A, Dziubek K, Kurkowiak M, Kote S, Kaźmierczak-siedlecka K, Połom K, Marek-trzonkowska N, Trzonkowski P. Autoimmunity and Cancer—Two Sides of the Same Coin. Front Immunol 2022;13:793234. [DOI: 10.3389/fimmu.2022.793234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Esposito JE, De Iuliis V, Avolio F, Liberatoscioli E, Pulcini R, Di Francesco S, Pennelli A, Martinotti S, Toniato E. Dissecting the Functional Role of the TRIM8 Protein on Cancer Pathogenesis. Cancers 2022;14:2309. [DOI: 10.3390/cancers14092309] [Reference Citation Analysis]
13 Susilo RJK, Winarni D, Hayaza S, Doong R, Wahyuningsih SPA, Darmanto W. Effect of crude Ganoderma applanatum polysaccharides as a renoprotective agent against carbon tetrachloride-induced early kidney fibrosis in mice. Vet World. [DOI: 10.14202/vetworld.2022.1022-1030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Katwa LC, Mendoza C, Clements M. CVD and COVID-19: Emerging Roles of Cardiac Fibroblasts and Myofibroblasts. Cells 2022;11:1316. [DOI: 10.3390/cells11081316] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Liu L, Sun Q, Davis F, Mao J, Zhao H, Ma D. Epithelial-mesenchymal transition in organ fibrosis development: current understanding and treatment strategies. Burns Trauma 2022;10:tkac011. [PMID: 35402628 DOI: 10.1093/burnst/tkac011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Wójcik-pszczoła K, Chłoń-rzepa G, Jankowska A, Ferreira B, Koczurkiewicz-adamczyk P, Pękala E, Wyska E, Pociecha K, Gosens R. Pan-Phosphodiesterase Inhibitors Attenuate TGF-β-Induced Pro-Fibrotic Phenotype in Alveolar Epithelial Type II Cells by Downregulating Smad-2 Phosphorylation. Pharmaceuticals 2022;15:423. [DOI: 10.3390/ph15040423] [Reference Citation Analysis]
17 Khalil HE, Ibrahim HM, El-fass KA, Akrawi SH, Morsy MA. Orientin Alleviates Liver Inflammation via Downregulation of ZEB-2/PTEN Markers—Hepatic Stellate Cells Approach. Applied Sciences 2022;12:2725. [DOI: 10.3390/app12052725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Gui Z, Suo C, Tao J, Wang Z, Zheng M, Fei S, Chen H, Sun L, Han Z, Ju X, Zhang H, Gu M, Tan R. Everolimus Alleviates Renal Allograft Interstitial Fibrosis by Inhibiting Epithelial-to-Mesenchymal Transition Not Only via Inducing Autophagy but Also via Stabilizing IκB-α. Front Immunol 2022;12:753412. [DOI: 10.3389/fimmu.2021.753412] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Wu B, Sodji QH, Oyelere AK. Inflammation, Fibrosis and Cancer: Mechanisms, Therapeutic Options and Challenges. Cancers 2022;14:552. [DOI: 10.3390/cancers14030552] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
20 Wang H, Zhang R, Wu X, Chen Y, Ji W, Wang J, Zhang Y, Xia Y, Tang Y, Yuan J. The Wnt Signaling Pathway in Diabetic Nephropathy. Front Cell Dev Biol 2021;9:701547. [PMID: 35059392 DOI: 10.3389/fcell.2021.701547] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Pei X, Zheng F, Li Y, Lin Z, Han X, Feng Y, Tian Z, Ren D, Cao K, Li C. Niclosamide Ethanolamine Salt Alleviates Idiopathic Pulmonary Fibrosis by Modulating the PI3K-mTORC1 Pathway. Cells 2022;11:346. [DOI: 10.3390/cells11030346] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Carluccio MA, Martinelli R, Massaro M, Calabriso N, Scoditti E, Maffia M, Verri T, Gatta V, De Caterina R. Nutrigenomic Effect of Hydroxytyrosol in Vascular Endothelial Cells: A Transcriptomic Profile Analysis. Nutrients 2021;13:3990. [PMID: 34836245 DOI: 10.3390/nu13113990] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
23 Newton DA, Lottes RG, Ryan RM, Spyropoulos DD, Baatz JE. Dysfunctional lactate metabolism in human alveolar type II cells from idiopathic pulmonary fibrosis lung explant tissue. Respir Res 2021;22:278. [PMID: 34711218 DOI: 10.1186/s12931-021-01866-x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
24 Lovisa S. Epithelial-to-Mesenchymal Transition in Fibrosis: Concepts and Targeting Strategies. Front Pharmacol 2021;12:737570. [PMID: 34557100 DOI: 10.3389/fphar.2021.737570] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
25 Jiménez-Uribe AP, Gómez-Sierra T, Aparicio-Trejo OE, Orozco-Ibarra M, Pedraza-Chaverri J. Backstage players of fibrosis: NOX4, mTOR, HDAC, and S1P; companions of TGF-β. Cell Signal 2021;87:110123. [PMID: 34438016 DOI: 10.1016/j.cellsig.2021.110123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
26 Kanlaya R, Subkod C, Nanthawuttiphan S, Thongboonkerd V. Caffeine prevents oxalate-induced epithelial-mesenchymal transition of renal tubular cells by its anti-oxidative property through activation of Nrf2 signaling and suppression of Snail1 transcription factor. Biomed Pharmacother 2021;141:111870. [PMID: 34246192 DOI: 10.1016/j.biopha.2021.111870] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Mattoo H, Pillai S. Idiopathic pulmonary fibrosis and systemic sclerosis: pathogenic mechanisms and therapeutic interventions. Cell Mol Life Sci 2021;78:5527-42. [PMID: 34145462 DOI: 10.1007/s00018-021-03874-y] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
28 Budi EH, Schaub JR, Decaris M, Turner S, Derynck R. TGF-β as a driver of fibrosis: physiological roles and therapeutic opportunities. J Pathol 2021;254:358-73. [PMID: 33834494 DOI: 10.1002/path.5680] [Cited by in Crossref: 6] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
29 Gui Z, Suo C, Wang Z, Zheng M, Fei S, Chen H, Sun L, Han Z, Tao J, Ju X, Yang H, Gu M, Tan R. Impaired ATG16L-Dependent Autophagy Promotes Renal Interstitial Fibrosis in Chronic Renal Graft Dysfunction Through Inducing EndMT by NF-κB Signal Pathway. Front Immunol 2021;12:650424. [PMID: 33927720 DOI: 10.3389/fimmu.2021.650424] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
30 Sisto M, Ribatti D, Lisi S. SMADS-Mediate Molecular Mechanisms in Sjögren's Syndrome. Int J Mol Sci 2021;22:3203. [PMID: 33801157 DOI: 10.3390/ijms22063203] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
31 Lombardi F, Augello FR, Palumbo P, Mollsi E, Giuliani M, Cimini AM, Cifone MG, Cinque B. Soluble Fraction from Lysate of a High Concentration Multi-Strain Probiotic Formulation Inhibits TGF-β1-Induced Intestinal Fibrosis on CCD-18Co Cells. Nutrients 2021;13:882. [PMID: 33803197 DOI: 10.3390/nu13030882] [Cited by in F6Publishing: 1] [Reference Citation Analysis]